Search
for
Sort by
Research 91–120 of 1000+
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- New Treatments for Hair Loss
- An accessible pharmacodynamic transcriptional biomarker for notch target engagement
- Cutaneous drug reactions
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- STAT3 Partly Inhibits Cell Proliferation via Direct Negative Regulation of FST Gene Expression
- Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Stimulation by exosomes from hypoxia-preconditioned hair follicle mesenchymal stem cells facilitates mitophagy by inhibiting the PI3K/AKT/mTOR signaling pathway to alleviate ulcerative colitis
- Lambertianic Acid from Platycladus orientalis Inhibits Muscle Atrophy in Dexamethasone-Induced C2C12 Muscle Atrophy Cells
- Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
- A skin organoid-based infection platform identifies an inhibitor specific for HFMD
- Stimulation of Hair Growth by Small Molecules that Activate Autophagy
- 650 Controlling mTORC1 activity as a novel therapeutic strategy for managing human hair growth and pigmentation
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Management of Dermatologic Toxicities
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells
- Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
- Immunohistochemical Analysis of the Mechanistic Target of Rapamycin and Hypoxia Signalling Pathways in Basal Cell Carcinoma and Trichoepithelioma
- Mechanisms of autophagy and their implications in dermatological disorders
- Primary TSC2-/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model